全文获取类型
收费全文 | 1427篇 |
免费 | 138篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 6篇 |
儿科学 | 28篇 |
妇产科学 | 5篇 |
基础医学 | 179篇 |
口腔科学 | 28篇 |
临床医学 | 149篇 |
内科学 | 292篇 |
皮肤病学 | 152篇 |
神经病学 | 112篇 |
特种医学 | 95篇 |
外科学 | 82篇 |
综合类 | 97篇 |
一般理论 | 1篇 |
预防医学 | 168篇 |
眼科学 | 30篇 |
药学 | 155篇 |
中国医学 | 1篇 |
肿瘤学 | 62篇 |
出版年
2020年 | 15篇 |
2019年 | 21篇 |
2018年 | 32篇 |
2017年 | 23篇 |
2016年 | 16篇 |
2015年 | 23篇 |
2014年 | 38篇 |
2013年 | 41篇 |
2012年 | 68篇 |
2011年 | 76篇 |
2010年 | 48篇 |
2009年 | 46篇 |
2008年 | 73篇 |
2007年 | 114篇 |
2006年 | 82篇 |
2005年 | 56篇 |
2004年 | 55篇 |
2003年 | 51篇 |
2002年 | 46篇 |
2001年 | 39篇 |
2000年 | 46篇 |
1999年 | 38篇 |
1998年 | 44篇 |
1997年 | 30篇 |
1996年 | 32篇 |
1995年 | 28篇 |
1994年 | 13篇 |
1993年 | 24篇 |
1992年 | 31篇 |
1991年 | 26篇 |
1990年 | 10篇 |
1989年 | 27篇 |
1988年 | 18篇 |
1987年 | 23篇 |
1986年 | 25篇 |
1985年 | 24篇 |
1984年 | 14篇 |
1983年 | 15篇 |
1982年 | 14篇 |
1981年 | 20篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1975年 | 11篇 |
1974年 | 9篇 |
1973年 | 11篇 |
1971年 | 14篇 |
1968年 | 16篇 |
排序方式: 共有1642条查询结果,搜索用时 31 毫秒
51.
52.
53.
Background Small intestinal bacterial overgrowth (SIBO) occurs in irritable bowel syndrome (IBS) and fibromyalgia. Since restless legs
syndrome (RLS) occurs with fibromyalgia, a link between IBS, SIBO, and RLS was studied. Methods BS patients with abnormal lactulose breath tests received rifaximin 1,200 mg day−1 for 10 days, followed by tegaserod 3 mg, long-term, and 1 month of zinc 220 mg day−1 and once-daily probiotic (N = 11) or rifaximin monotherapy (N = 2). IBS symptom improvement was assessed after rifaximin. RLS symptoms, IBS symptoms, and overall IBS global improvement
were assessed at last posttreatment visit: 8/10 patients were followed long-term (mean, 139 days; range, 54–450 days). Results Ten of 13 patients exhibited ≥80% improvement from baseline in RLS symptoms. Five maintained complete resolution of RLS symptoms.
Global gastrointestinal symptom improvement was great (n = 6), moderate (n = 5), or mild (n = 2). Conclusion This study suggests that SIBO associated with IBS may be a factor in some RLS patients and SIBO therapy provides long-term
RLS improvement. 相似文献
54.
Effect of n-3 and n-6 fatty acids on proliferation and differentiation of promyelocytic leukemic HL-60 cells 总被引:9,自引:0,他引:9
Finstad HS; Kolset SO; Holme JA; Wiger R; Farrants AK; Blomhoff R; Drevon CA 《Blood》1994,84(11):3799-3809
Promyelocytic leukemic HL-60 cells were incubated with different fatty acids. Arachidonic acid (AA; 20:4, n-6) and eicosapentaenoic acid (EPA; 20:5, n-3) were the most potent inhibitors of proliferation in a dose- dependent way. Retinoic acid (RA) was used as a positive control. Inhibitors of cyclooxygenase and lipoxygenase or addition of antioxidants did not influence the effect of EPA or AA on cell proliferation. Increased capacity to generate superoxide anions after phorbol ester treatment and a reduced serglycin messenger RNA level in cells treated with AA or EPA indicated that these fatty acids induced differentiation in HL-60 cells similar to that induced by RA. However, down-regulation of the c-myc mRNA level, also typical for differentiation with RA in HL-60 cells, was not observed in cells incubated with AA or EPA. Flow cytometric analyses showed that in cultures incubated with AA or EPA, the proportion of cells in the G1 phase of the cell cycle increased. Similar effects were observed with RA. By flow cytometry and light scatter analyses it could be shown that AA made 8% of the cells apoptotic and 7% necrotic. The corresponding numbers were 21% and 10% for RA-treated cells, and 19% and 32% for EPA- treated cells. The present study shows that AA and EPA reduce the proliferation rate of HL-60 cells. This is mediated by mechanisms independent of eicosanoids or lipid peroxidation products and is due to effects both on apoptosis/necrosis and cell differentiation. 相似文献
55.
Impact of the basic skin cancer triage curriculum on providers’ skin cancer control practices 下载免费PDF全文
Mikkilineni R Weinstock MA Goldstein MG Dube CE Rossi JS 《Journal of general internal medicine》2001,16(5):302-307
OBJECTIVE: To evaluate the effect of a 2-hour, multicomponent educational intervention on provider skin cancer control practices. DESIGN: Nonrandomized intervention study. The intervention was a 2-hour curriculum designed to augment provider skin cancer control practices through instruction in basic skin cancer triage (BSCT) and a brief summary of skin cancer epidemiology, prevention, and counseling. SETTING: Five staff-model health maintenance organizations in southeastern New England. PARTICIPANTS: Convenience sample of primary care providers. Providers older than age 75, individuals in practice for less than 1 year, or individuals planning to retire in the next 2 years were excluded from the study. Twenty-two of 28 participants completed the study. RESULTS: Providers completed preintervention and postintervention surveys asking them to rate their attitudes towards skin examination and skin cancer counseling and to rate the frequency of their skin cancer control practices, using 5-point Likert scales. We independently assessed provider behavior through surveys of their patients, eliciting information on provider practices before and after BSCT participation. Following participation in the curriculum, there was significant improvement in provider attitudes towards the total body skin examination but not towards skin cancer prevention counseling. Significant increases in provider self- reported skin cancer control practices during an initial visit with a new patient (2.17 to 3.21, P <.0001) and a routine visit with a patient at high risk for melanoma (2.15 to 3.00, P <.0001) were demonstrated. Analysis of the patient exit interviews independently confirmed these changes in practice patterns. CONCLUSIONS: The study results suggest that the BSCT curriculum may be a useful tool in increasing the practice of skin cancer control measures by primary care providers. 相似文献
56.
Monoclonal antibody to the gastrin receptor on parietal cells recognizes a 78-kDa protein. 总被引:1,自引:0,他引:1 下载免费PDF全文
F T Mu G Baldwin J Weinstock D Stockman B H Toh 《Proceedings of the National Academy of Sciences of the United States of America》1987,84(9):2698-2702
Four monoclonal antibodies reactive by immunofluorescence and by flow microfluorimetry with canine and porcine gastric parietal cell membranes were produced by fusion of mouse NS-1 myeloma cells with splenocytes from mice immunized with a population of canine gastric mucosal cells containing 60-70% parietal cells. One of these, an IgM antibody designated 2C1, reacted with the surface membranes of parietal cells by immunofluorescence, flow microfluorimetry, and immunogold electron microscopy; competed with 125I-labeled gastrin for binding to gastric cells; and inhibited by 56% maximal gastrin stimulation of [14C]aminopyrine uptake in parietal cells. The antibody immunoprecipitated 125I-labeled samples of a 78-kDa gastrin-binding protein purified from membrane extracts of porcine gastrin mucosa but did not recognize the same protein labeled covalently with 125I-labeled gastrin-(2-17)-hexadecapeptide. These observations suggest that the previously identified 78-kDa gastrin-binding protein is the gastrin receptor and that the antibody 2C1 is directed against the gastrin binding site of the gastrin receptor. 相似文献
57.
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen 总被引:1,自引:0,他引:1
We have studied the use of a new preparative regimen for the treatment of patients in remission of acute myeloid leukemia (AML) with autologous bone marrow transplantation. Chemotherapy consisted of busulfan 1 mg/kg every 6 hours for 4 days (total dose, 16 mg/kg) on days -7 through -4 followed by an intravenous infusion over 6 to 10 hours of etoposide 60 mg/kg on day -3. Autologous bone marrow, treated in vitro with 100 micrograms/mL of 4-hydroperoxycyclophosphamide, was infused on day 0. We have treated 58 patients up to the age of 60 years, 32 in first remission, 21 in second or third remission, and 5 with primary refractory AML unresponsive to high-dose Ara-C, but achieving remission with aggressive salvage regimens. Of the first remission patients, there has been 1 treatment related death and 5 relapses. With median follow-up of 22 months, the actuarial relapse rate is 22% +/- 9% and disease-free survival is 76% +/- 9% at 3 years. Patients with favorable French-American-British (FAB) subtypes (M3 or M4 EO) did especially well, with no relapses seen in 15 patients observed for a median of 30 months. Actuarial relapse rate at 3 years was 48% for first remission patients with less favorable FAB subtypes. Of patients in second or third remission, there were 5 treatment related deaths and 4 relapses. With median follow-up of 22 months, the actuarial relapse rate is 25% +/- 11% and disease-free survival is 56% +/- 11% at 3 years. Four of five primary refractory patients died during treatment and 1 remains in remission with short follow-up. These preliminary data are very encouraging and, if confirmed, support the use of autologous purged bone marrow transplantation using aggressive preparative regimens as one approach to improve the outcome of adults with AML. 相似文献
58.
Open reading frame expression vectors: a general method for antigen production in Escherichia coli using protein fusions to beta-galactosidase. 总被引:29,自引:9,他引:29 下载免费PDF全文
59.
Targeting oncogenic interleukin‐7 receptor signalling with N‐acetylcysteine in T cell acute lymphoblastic leukaemia 下载免费PDF全文
Marc R. Mansour Casie Reed Amy R. Eisenberg Jen‐Chieh Tseng Jean‐Claude Twizere Sarah Daakour Akinori Yoda Scott J. Rodig Noa Tal Chen Shochat Alla Berezovskaya Daniel J. DeAngelo Stephen E. Sallan David M. Weinstock Shai Izraeli Andrew L. Kung Alex Kentsis A. Thomas Look 《British journal of haematology》2015,168(2):230-238
Activating mutations of the interleukin‐7 receptor (IL7R) occur in approximately 10% of patients with T cell acute lymphoblastic leukaemia (T‐ALL). Most mutations generate a cysteine at the transmembrane domain leading to receptor homodimerization through disulfide bond formation and ligand‐independent activation of STAT5. We hypothesized that the reducing agent N‐acetylcysteine (NAC), a well‐tolerated drug used widely in clinical practice to treat acetaminophen overdose, would reduce disulfide bond formation, and inhibit mutant IL7R‐mediated oncogenic signalling. We found that treatment with NAC disrupted IL7R homodimerization in IL7R‐mutant DND‐41 cells as assessed by non‐reducing Western blot, as well as in a luciferase complementation assay. NAC led to STAT5 dephosphorylation and cell apoptosis at clinically achievable concentrations in DND‐41 cells, and Ba/F3 cells transformed by an IL7R‐mutant construct containing a cysteine insertion. The apoptotic effects of NAC could be rescued in part by a constitutively active allele of STAT5. Despite using doses lower than those tolerated in humans, NAC treatment significantly inhibited the progression of human DND‐41 cells engrafted in immunodeficient mice. Thus, targeting leukaemogenic IL7R homodimerization with NAC offers a potentially effective and feasible therapeutic strategy that warrants testing in patients with T‐ALL. 相似文献
60.